Spots Global Cancer Trial Database for Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Official Title: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Study ID: NCT00172003
Interventions
Study Description
Brief Summary: It is the aim of this clinical study to evaluate the skeletal-related event rate under therapy with zoledronic acid in patients with renal cell cancer having at least one cancer-related bone lesion.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis investigative Site, Offenbach, , Germany
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmeceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
